Distribution Agreement in Saudi Arabia and Jordan
News Jul 10, 2015
RaySearch Laboratories AB (publ.) has entered into a long-term distribution agreement with Trading Medical Systems Jordan (TMSJ) in Amman, Jordan. According to the agreement, TMSJ assumes full responsibility for the marketing, sales and service of RaySearch’s treatment planning system, RayStation®, in the markets of Saudi Arabia and Jordan.
TMSJ is a leading distributor of medical equipment used in the treatment of cancer and represents a wide range of respected international suppliers. The company was founded in 1995 and is well established in the radiation therapy, radiology and dosimetry market in Jordan with a dedicated and highly experienced sales and support team.
“TMSJ is honored to be representing RaySearch, that has a distinguished reputation to deliver highly innovative treatment planning solutions, in Saudi Arabia and Jordan. We are looking forward to promoting RayStation® to our customers in the region”, says Faris Al-Said, CEO of Trading Medical Systems Jordan.
“RayStation® is established as a world leading treatment planning system for radiation therapy and so far it has been sold to 20 different countries. We are excited to work with such an experienced partner as TMSJ to introduce RayStation® in Saudi Arabia and Jordan in order to serve customers in those countries in the best possible way”, says Johan Löf, CEO of RaySearch.
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Improved Capture of Free-Floating Cancer Cells, Cast-Off from TumorsNews
Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center and University of Wisconsin-Madison have demonstrated improved methods of capturing free-floating cancer cells that are cast-off from tumors, and circulating in the blood.READ MORE
Biomarkers to Personalize Treatment of Head and Neck CancerNews
Researchers at A.C. Camargo Cancer Center in Brazil have found markers in the blood of head and neck cancer patients that can help identify cases that are likely to evolve to metastasis or develop local relapse after treatment.READ MORE